KALA-AZAR, SUSCEPTIBILITY TO, 2
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Osteoporosis with pseudoglioma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
12
|
37
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Malignant Squamous Cell Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
193
|
12
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Barrett Epithelium
|
disease |
Digestive System Diseases; Neoplasms
|
Disease or Syndrome
|
52
|
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Malignant neoplasm of pharynx
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
37
|
9
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Cortical cataract
|
disease |
Eye Diseases
|
Disease or Syndrome
|
69
|
15
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Age-related cataract
|
disease |
Eye Diseases
|
Acquired Abnormality
|
92
|
15
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Disorder of eye
|
group |
Eye Diseases
|
Disease or Syndrome
|
400
|
14
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Cataract
|
disease |
Eye Diseases
|
Acquired Abnormality
|
878
|
124
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Undifferentiated carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
283
|
8
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Nodular Lymphocyte Predominant Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
51
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Adult Erythroleukemia
|
disease |
|
Neoplastic Process
|
236
|
4
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Treatment related acute myeloid leukaemia
|
disease |
|
Neoplastic Process
|
65
|
4
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Carcinoma, Spindle-Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
218
|
5
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Carcinomatosis
|
phenotype |
Neoplasms
|
Neoplastic Process
|
186
|
2
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Hodgkin lymphoma, lymphocyte depletion
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Lymphocyte Rich Classical Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
15
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
premalignant lesion
|
phenotype |
|
Neoplastic Process
|
20
|
5
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Erythroleukemia (Erythroid/Myeloid)
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
237
|
4
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Acute Erythroblastic Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
302
|
5
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Carcinoma of larynx
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
456
|
65
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Carcinoid Tumor
|
phenotype |
Neoplasms
|
Neoplastic Process
|
267
|
3
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Mixed Cellularity Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
19
|
3
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Malignant neoplasm of larynx
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
349
|
50
|
0.030 |
None |
0.667 |
3 |
|
1999 |
2002 |